BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10418040)

  • 1. Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSF) using amplicor HIV-1 monitor test.
    Honderlick P; Zucman D; Couderc LJ
    Pathol Biol (Paris); 1999 May; 47(5):560-2. PubMed ID: 10418040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
    Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
    Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART].
    Corti ME; Villafañe MF; Baré P; Alves Rosa F; Cermelj M; Candela M; Pérez Bianco R; Tezanos Pinto M
    Medicina (B Aires); 2001; 61(6):821-4. PubMed ID: 11808421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Borodowsky I; Subbakrishna DK; Kumar M
    J Clin Virol; 2007 May; 39(1):9-15. PubMed ID: 17368087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment.
    Schmid I; Arrer E; Hawranek T; Patsch W
    Clin Lab; 2000; 46(7-8):355-60. PubMed ID: 10934582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
    Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
    J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
    Tambussi G; Gori A; Capiluppi B; Balotta C; Papagno L; Morandini B; Di Pietro M; Ciuffreda D; Saracco A; Lazzarin A
    Clin Infect Dis; 2000 Jun; 30(6):962-5. PubMed ID: 10880317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma.
    Bergroth T; Ekici H; Gisslén M; Hagberg L; Sönnerborg A
    HIV Med; 2009 Feb; 10(2):111-5. PubMed ID: 19200174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the sensitivities and viral load values of the AMPLICOR HIV-1 MONITOR version 1.0 and 1.5 tests.
    Caliendo AM; Ingersoll J; Green AM; Nolte FS; Easley KA
    J Clin Microbiol; 2004 Nov; 42(11):5392-3. PubMed ID: 15528752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.
    Ellis RJ; Childers ME; Zimmerman JD; Frost SD; Deutsch R; McCutchan JA;
    J Infect Dis; 2003 Jun; 187(11):1818-21. PubMed ID: 12751041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
    Enting RH; Prins JM; Jurriaans S; Brinkman K; Portegies P; Lange JM
    Clin Infect Dis; 2001 Apr; 32(7):1095-9. PubMed ID: 11264039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
    Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
    Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
    Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
    Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
    Swanson P; Huang S; Abravaya K; de Mendoza C; Soriano V; Devare SG; Hackett J
    J Virol Methods; 2007 Apr; 141(1):49-57. PubMed ID: 17184853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.